#NPPA
NPPA extends knee implant price ceiling till January 2027 amid mark-up row | Health News

Amid recent judicial scrutiny of high price mark-ups on medical devices and drugs, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation for orthopaedic knee implants […]
Original post on mastodon.social
mastodon.social
November 16, 2026 at 3:12 PM
NPPA extends knee implant price ceiling till January 2027 amid mark-up row | Health News

Amid recent judicial scrutiny of high price mark-ups on medical devices and drugs, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation for orthopaedic knee implants…
NPPA extends knee implant price ceiling till January 2027 amid mark-up row | Health News
Amid recent judicial scrutiny of high price mark-ups on medical devices and drugs, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation for orthopaedic knee implants used in knee replacement systems for at least two more months, till January 2027.   In a notification dated November 13, the drug price regulator said the fixed price ceiling shall remain in force for orthopaedic knee implants for a further period of up to two months, that is, till January 15, 2027, unless amended by a subsequent notification.
thesbharat.com
November 16, 2026 at 3:12 PM
Centre directs states to monitor compliance with cancer drug margin caps | Industry News

India’s apex drug pricing control body, the National Pharmaceutical Pricing Authority (NPPA), has asked all state drug controllers (SDCs) to strictly monitor industry compliance with revised maximum retail…
Centre directs states to monitor compliance with cancer drug margin caps | Industry News
India’s apex drug pricing control body, the National Pharmaceutical Pricing Authority (NPPA), has asked all state drug controllers (SDCs) to strictly monitor industry compliance with revised maximum retail prices (MRPs) of cancer drugs after trade margin capping.   This comes four days after an NPPA-backed 30 per cent trade margin cap for 137 non-scheduled cancer drugs, translating to 1,391 brands and dosage forms, came into effect on November 9.
thesbharat.com
November 14, 2026 at 2:51 PM
"The financial side of the project has also raised serious concerns. Egypt’s NPPA has accused Rosatom of withholding payments from local subcontractors, including Hassan Allam and Petrojet."

Russia is "withholding" payments from many...

...and Trump, Kushner, and Witkoff seek business deals?
frontelligence.substack.com/p/russias-nu...

Russia screws up Egypt nuclear project.

Egypt demands the removal of Russian project director after failures, serious concrete defects in the foundations, missed construction deadlines, cost overruns, and lying about the true state of construction.
Russia’s Nuclear Troubles in Egypt
Exclusive: Inside Rosatom’s El Dabaa Fallout
frontelligence.substack.com
November 12, 2026 at 10:06 AM
Centre directs states to monitor compliance with cancer drug margin caps | Industry News

India’s apex drug pricing control body, the National Pharmaceutical Pricing Authority (NPPA), has asked all state drug controllers (SDCs) to strictly monitor industry compliance with revised maximum retail […]
Original post on mastodon.social
mastodon.social
November 14, 2026 at 2:50 PM
Centre cuts MRPs for trade-margin-capped cancer meds by up to 93% | Economy & Policy News

India’s drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has revised the maximum retail prices (MRPs) of 543 trade margin-capped cancer drug brands and pack sizes, with […]
Original post on mastodon.social
mastodon.social
November 14, 2026 at 6:10 PM
SpicyIP Weekly Review (November 2 — November 8)

After a long weekend, we’re back with our weekly roundup of important and interesting IP updates, featuring posts on the NPPA TMR order, ABS, and a comment on evidence-based IP policymaking. (1/2)
November 12, 2026 at 10:42 AM
137 कैंसर रोधी औषधियों की संशोधित कीमतें 09 नवंबर 2026 से प्रभावी

अधिक मूल्य वसूली अथवा औषधि की अनुपलब्धता की शिकायत कराएँ दर्ज रायपुर । राष्ट्रीय औषधि मूल्य निर्धारण प्राधिकरण (NPPA), भारत सरकार द्वारा 137 गैर-अनुसूचित कैंसर रोधी औषधियों पर Trade Margin Rationalisation (TMR) लागू किया गया है।…
137 कैंसर रोधी औषधियों की संशोधित कीमतें 09 नवंबर 2026 से प्रभावी
अधिक मूल्य वसूली अथवा औषधि की अनुपलब्धता की शिकायत कराएँ दर्ज रायपुर । राष्ट्रीय औषधि मूल्य निर्धारण प्राधिकरण (NPPA), भारत सरकार द्वारा 137 गैर-अनुसूचित कैंसर रोधी औषधियों पर Trade Margin Rationalisation (TMR) लागू किया गया है। इसके अंतर्गत औषधियों के संशोधित अधिकतम खुदरा मूल्य (MRP) दिनांक 09.11.2026 से प्रभावशील हैं। छत्तीसगढ़ राज्य में संशोधित कीमतों का लाभ कैंसर रोगियों तक पहुँचाने के उद्देश्य से CGPMRU द्वारा संबंधित औषधि विक्रेताओं, अस्पतालों एवं चिकित्सा संस्थानों को संशोधित MRP का अनुपालन सुनिश्चित करने, मूल्य सूची प्रदर्शित करने तथा निर्धारित मूल्य से अधिक राशि नहीं वसूलने हेतु परिपत्र जारी किया गया है।
apnachhattisgarh.com
November 13, 2026 at 4:57 PM
Patients can check prices on the Pharma Sahi Daam app or the NPPA website, and can report overcharging to the authority's toll-free helpline, which the order did not change.
November 10, 2026 at 5:13 PM
US deports Rwandan national accused of involvement in genocide

A man accused of participating in Rwanda's 1994 genocide has ​been deported by the United States to ‌stand trial, Rwanda's public prosecutor said in a statement. The Rwanda National Public Prosecution Authority (NPPA) indicted Jean…
US deports Rwandan national accused of involvement in genocide
A man accused of participating in Rwanda's 1994 genocide has ​been deported by the United States to ‌stand trial, Rwanda's public prosecutor said in a statement. The Rwanda National Public Prosecution Authority (NPPA) indicted Jean ​Léonard Teganya in 2014 for "alleged involvement in ​the crimes of genocide and crimes against ⁠humanity during the 1994 genocide," NPPA ​said in the statement late on Monday…
geoxaxis.com
November 10, 2026 at 12:52 PM
Government Caps Trade Margins on 137 Anti-Cancer Drugs at 30% of MRP; Patients Stand to Save Over ₹3,500 Crore

New Delhi: In a significant move to make cancer treatment more affordable, the National Pharmaceutical Pricing Authority (NPPA) on 17 October 2026 limited the trade margin on 137 […]
Original post on mastodon.social
mastodon.social
November 11, 2026 at 9:36 AM
The Pharma Sahi Daam app, built to help patients find cheaper brands of the same drug, continues to sort results from lowest price to highest. An NPPA official said the order did not affect the sorting, only what was being sorted.
November 10, 2026 at 5:13 PM
पिछले 30 मिनट के विषय 🧭:

1. NPPA 🆕
November 8, 2026 at 6:30 PM
We apologise for the delay in bringing you this week’s edition, which is going out a little later than usual. This, and much more, in this edition of the SpicyIP Weekly Review! Anything we missed? Drop a comment and let us know. (2/2)
spicyip.com/2026/11/spic...
SpicyIP Weekly Review (November 2 — November 8)
After a long weekend, we’re back with our weekly roundup of important and interesting IP updates, featuring posts on the NPPA TMR order, ABS, and a comment on evidence-based IP policymaking. …
spicyip.com
November 12, 2026 at 10:42 AM
PIB India Government News on 13th November (Competitive Exam Special)

Here are today's important PIB GoI updates: India and Italy to strengthen scientific cooperation under strategic partnership, with new joint research call planned for 2027…...
PIB India Government News on 13th November (Competitive Exam Special)
Here are today's important PIB GoI updates: India and Italy to strengthen scientific cooperation under strategic partnership, with new joint research call planned for 2027 Prime Minister inaugurates various development projects in Bengaluru 57th Indian International Film Festival (IFFI) 2026 to be held in Goa with theme "Stories Beyond Borders" NPPA directs strict monitoring of implementation of Trade Margin Rationalization (TMR) on 137 anti-cancer drugs…
citizenspoint.com
November 13, 2026 at 12:31 PM
Government Caps Trade Margins on 137 Anti-Cancer Drugs at 30% of MRP; Patients Stand to Save Over ₹3,500 Crore

New Delhi: In a significant move to make cancer treatment more affordable, the National Pharmaceutical Pricing Authority (NPPA) on 17 October 2026 limited the trade margin on 137…
Government Caps Trade Margins on 137 Anti-Cancer Drugs at 30% of MRP; Patients Stand to Save Over ₹3,500 Crore
New Delhi: In a significant move to make cancer treatment more affordable, the National Pharmaceutical Pricing Authority (NPPA) on 17 October 2026 limited the trade margin on 137 non-scheduled anti-cancer drugs to a maximum of 30 per cent of the Maximum Retail Price (MRP). The revised prices came into effect from 9 November 2026. By 9 November 2026, 85 companies had notified revised MRPs for 121 drugs covering 1,366 stock-keeping units (SKUs).
thesbharat.com
November 11, 2026 at 9:37 AM
Revised prices for 1,364 anti-cancer drug formulations have come into effect across India, and the anti-cancer medicine prices now in force follow a cap on trade margins by the…
Anti-cancer medicine prices cut up to 96% in India
Anti-cancer medicine prices: revised MRPs for 1,364 formulations took effect on 9 November after the NPPA capped trade margins at 30% of MRP.
trendsnewsstories.com
November 11, 2026 at 3:42 AM
As on date, 76 #pharmaceuticalcompanies have reported revised MRP for 1225 anti-cancer formulations, covering 121 drugs.

www.newsinc24.com/news/-contin...
Cancer drug prices slashed drastically, NPPA caps trade margins
constituted by the DGHS.
www.newsinc24.com
November 9, 2026 at 8:10 AM
NPPA caps trade margins on 137 anti-cancer drugs; revised prices take effect Nov 9

The National Pharmaceutical Pricing Authority capped trade margins on 137 anti-cancer drugs and said revised prices will be effective from November 9, 2026.

https://v3.news/e/q7m3gzw
November 8, 2026 at 5:02 PM
अब सस्ता होगा कैंसर का इलाज! 600 ब्रांड की दवाओं की कीमतों में 50% से ज्यादा कमी

कैंसर मरीजों को राहत देते हुए NPPA ने 137 कैंसर रोधी दवाओं पर व्यापार मार्जिन की सीमा तय की है। 600 ब्रांड की दवाओं की कीमतों में 50% से अधिक की कमी दर्ज की गई है।
अब सस्ता होगा कैंसर का इलाज! 600 ब्रांड की दवाओं की कीमतों में 50% से ज्यादा कमी
कैंसर मरीजों को राहत देते हुए NPPA ने 137 कैंसर रोधी दवाओं पर व्यापार मार्जिन की सीमा तय की है। 600 ब्रांड की दवाओं की कीमतों में 50% से अधिक की कमी दर्ज की गई है।
jagrukrashtra.com
November 8, 2026 at 6:11 PM
Indien begrenzt Handelsmargen bei 137 Krebsmedikamenten: teils drastische Preissenkungen, aber Entlastung mit großen Unterschieden #Indien #Gesundheit
Indien begrenzt Handelsmargen bei 137 Krebsmedikamenten: teils drastische Preissenkungen, aber Entlastung mit großen Unterschieden
Neue Preise gelten ab dem 9. November, doch die Einsparungen hängen vom Medikament ab Indiens Nationale Behörde für Arzneimittelpreise (NPPA) hat für 137 Krebsmedikamente ab dem 9. November 2026 eine Obergrenze von 30 Prozent für die Handelsmargen angeordnet. Für einige…
de.asiadaily.org
November 7, 2026 at 2:22 AM